Basics Erasca, Inc. IPO Date: July 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $403.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 3.66% Avg Daily Range (30 D): $0.06 | 4.88% Avg Daily Range (90 D): $0.06 | 4.78% Institutional Daily Volume Avg Daily Volume: .85M Avg Daily Volume (30 D): 1.24M Avg Daily Volume (90 D): 1.34M Trade Size Avg Trade Size (Sh.): 135 Avg Trade Size (Sh.) (30 D): 183 Avg Trade Size (Sh.) (90 D): 191 Institutional Trades Total Inst.Trades: 418 Avg Inst. Trade: $2M Avg Inst. Trade (30 D): $2.64M Avg Inst. Trade (90 D): $1.66M Avg Inst. Trade Volume: .43M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.87M Avg Closing Trade (30 D): $3M Avg Closing Trade (90 D): $2.79M Avg Closing Volume: 581.03K     News May 29, 2025 @ 12:00 PM Erasca to Present at Upcoming Investor Conferences... Source: Na Jan 31, 2025 @ 1:00 PM Erasca to Present at the Guggenheim Securities SMI... Source: N/A Dec 26, 2024 @ 4:26 PM Oncology in Focus: How Emerging Therapies Are Resh... Source: Prnewswire Nov 5, 2024 @ 1:00 PM Erasca to Present at Upcoming Investor Conferences... Source: N/A Jun 4, 2024 @ 1:55 PM Should You Buy Erasca, Inc. (ERAS) After Golden Cr... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.11 $-.09 $-.69 Diluted EPS $-.11 $-.09 $-.69 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -30.97M $ -32.23M $ -161.65M Operating Income / Loss $ -35.63M $ -35.71M $ -179.59M Cost of Revenue $ $ $ Net Cash Flow $ 2.74M $ -1.15M $ -25.34M PE Ratio